Showing results (151-160 of 243) with videos related to
Sort By:
Pageof 25
European Journal of Cancer (Oxford, England : 1990)|January 30, 2021
Tumour-infiltrating lymphocyte density is associated with favourable outcome in patients with advanced non-small cell lung cancer treated with immunotherapyIthar Gataa, Laura Mezquita, Caroline Rossoni, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 29, 2021
Phase 2 Study of Dabrafenib Plus Trametinib in Patients With BRAF V600E-Mutant Metastatic NSCLC: Updated 5-Year Survival Rates and Genomic AnalysisDavid Planchard, Benjamin Besse, Harry J M Groen, et al.Lung Cancer (Amsterdam, Netherlands)|January 16, 2019
Real-life efficacy of osimertinib in pretreated patients with advanced non-small cell lung cancer harboring EGFR T790M mutationJean Bernard Auliac, Maurice Pérol, David Planchard, et al.Cancers|October 3, 2020
Impact of Intercurrent Introduction of Steroids on Clinical Outcomes in Advanced Non-Small-Cell Lung Cancer (NSCLC) Patients under Immune-Checkpoint Inhibitors (ICI)Andrea De Giglio, Laura Mezquita, Edouard Auclin, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 12, 2017
Nintedanib Plus Pemetrexed/Cisplatin in Patients With Malignant Pleural Mesothelioma: Phase II Results From the Randomized, Placebo-Controlled LUME-Meso TrialFederica Grosso, Nicola Steele, Silvia Novello, et al.Lung Cancer (Amsterdam, Netherlands)|August 21, 2009
A randomized phase II study of bortezomib and pemetrexed, in combination or alone, in patients with previously treated advanced non-small-cell lung cancerGiorgio V Scagliotti, Paul Germonpré, Leon Bosquée, et al.Future Oncology (London, England)|December 30, 2025
The first United Arab Emirates expert consensus recommendations for the diagnosis and management of early and advanced non-small cell lung cancerHumaid Al Shamsi, Nadia Abdelwahed, Hassan Jaafar, et al.European Radiology|April 24, 2020
Association of metastatic pattern and molecular status in stage IV non-small cell lung cancer adenocarcinomaAlison Dormieux, Laura Mezquita, Paul Henry Cournede, et al.Nature Medicine|April 26, 2022
Digital remote monitoring plus usual care versus usual care in patients treated with oral anticancer agents: the randomized phase 3 CAPRI trialOlivier Mir, Marie Ferrua, Aude Fourcade, et al.European Journal of Cancer (Oxford, England : 1990)|June 21, 2021
Impact of COVID-19 on healthcare organisation and cancer outcomesAurelie Bardet, Alderic M Fraslin, Jamila Marghadi, et al.Pageof 25